Showing results (181-190 of 283) with videos related to
Sort By:
Pageof 29
Hepatology (Baltimore, Md.)|June 1, 2011
Rapid emergence of telaprevir resistant hepatitis C virus strain from wildtype clone in vivoNobuhiko Hiraga, Michio Imamura, Hiromi Abe, et al.Antimicrobial Agents and Chemotherapy|January 29, 2014
Ultradeep sequencing study of chronic hepatitis C virus genotype 1 infection in patients treated with daclatasvir, peginterferon, and ribavirinEisuke Murakami, Michio Imamura, C Nelson Hayes, et al.The Journal of Infectious Diseases|February 28, 2022
Hepatitis B Virus (HBV) Upregulates TRAIL-R3 Expression in Hepatocytes Resulting in Escape From Both Cell Apoptosis and Suppression of HBV Replication by TRAILYosuke Suehiro, Masataka Tsuge, Mio Kurihara, et al.Journal of Hepatology|December 15, 2010
Elimination of hepatitis C virus by short term NS3-4A and NS5B inhibitor combination therapy in human hepatocyte chimeric miceEiji Ohara, Nobuhiko Hiraga, Michio Imamura, et al.Antiviral Therapy|June 2, 2018
Reduction of hepatitis B surface antigen in sequential versus add-on pegylated interferon to nucleoside/nucleotide analogue therapy in HBe-antigen-negative chronic hepatitis B patients: a pilot studyYumiko Tatsukawa, Masataka Tsuge, Yoshiiku Kawakami, et al.Biochemical and Biophysical Research Communications|October 22, 2013
A novel TK-NOG based humanized mouse model for the study of HBV and HCV infectionsKeiichi Kosaka, Nobuhiko Hiraga, Michio Imamura, et al.Journal of Gastroenterology|March 5, 2016
Antiviral effects of anti-HBs immunoglobulin and vaccine on HBs antigen seroclearance for chronic hepatitis B infectionMasataka Tsuge, Nobuhiko Hiraga, Takuro Uchida, et al.Journal of Gastroenterology|October 12, 2012
Risk factors for the exacerbation of esophageal varices or portosystemic encephalopathy after sustained virological response with IFN therapy for HCV-related compensated cirrhosisYuko Nagaoki, Hiroshi Aikata, Tomoki Kobayashi, et al.Journal of Gastroenterology and Hepatology|December 20, 2021
Underestimation of impaired glucose tolerance and usefulness of a continuous glucose monitoring system in chronic liver diseaseYutaro Ogawa, Takashi Nakahara, Masafumi Ono, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 24, 2013
Non-invasive liver fibrosis score calculated by combination of virtual touch tissue quantification and serum liver functional tests in chronic hepatitis C patientsShintaro Takaki, Yoshiiku Kawakami, Daisuke Miyaki, et al.Pageof 29